Sign Up to like & get
recommendations!
0
Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa4290
Abstract: Introduction: In patients without targeted-mutations platinum-based chemotherapy is still current treatment method with a median survival rates of 8-11 months. Patients with single side oligo-metastatic disease should be consider for curative aggressive therapies for both…
read more here.
Keywords:
survival prognostic;
surgery months;
months surgery;
months crt ... See more keywords